Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.
Zlobec
Inti
I
Institute for Pathology, University Hospital Basel, Basel, Switzerland. izlobec@uhbs.ch
Molinari
Francesca
F
Martin
Vittoria
V
Mazzucchelli
Luca
L
Saletti
Piercarlo
P
Trezzi
Rosangela
R
De Dosso
Sara
S
Vlajnic
Tatjana
T
Frattini
Milo
M
Lugli
Alessandro
A